Ningbo Menovo Pharmaceutical Co., Ltd.

SHSE:603538 Voorraadrapport

Marktkapitalisatie: CN¥2.9b

Ningbo Menovo Pharmaceutical Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Cheng Zhi Yao

Algemeen directeur

CN¥609.5k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO5.5%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Ningbo Menovo Pharmaceutical's (SHSE:603538) Problems Go Beyond Weak Profit

Nov 05
Ningbo Menovo Pharmaceutical's (SHSE:603538) Problems Go Beyond Weak Profit

Benign Growth For Ningbo Menovo Pharmaceutical Co., Ltd. (SHSE:603538) Underpins Its Share Price

Apr 17
Benign Growth For Ningbo Menovo Pharmaceutical Co., Ltd. (SHSE:603538) Underpins Its Share Price

CEO

Cheng Zhi Yao (50 yo)

no data

Tenure

CN¥609,500

Compensatie

Mr. Yao, Cheng Zhi serves as Chairman of the Board and General Manager at Ningbo Menovo Pharmaceutical Co., Ltd.